Royal Bank Of Canada Lucid Diagnostics Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.67 - $1.04 $71 - $111	107 Added 120.22%	196 $0
Q1 2024 Nov 05, 2024	SELL	$0.81 - $1.52 $86 - $162	-107 Reduced 54.59%	89 $0
Q1 2024 May 15, 2024	SELL	$0.81 - $1.52 $88 - $165	-109 Reduced 55.05%	89 $0
Q4 2023 Feb 14, 2024	BUY	$1.16 - $1.54 $229 - $304	198 New	198 $0
Q2 2023 Aug 14, 2023	BUY	$1.28 - $1.78 $121 - $169	95 New	95 $0
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.44 $1,574 - $3,130	-910 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.85 - $5.24 $2,177 - $4,003	-764 Reduced 45.64%	910 $3,000
Q4 2021 Feb 14, 2022	BUY	$4.87 - $11.76 $8,152 - $19,686	1,674 New	1,674 $9,000

2.54M

Ticker LUCD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 38,568,500
Market Cap $38.6M
Description
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.